Xenon Pharmaceuticals

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics to treat neurological disorders. They generate revenue primarily through partnerships, licensing agreements, and milestone payments from their drug development collaborations. Founded in 1996, Xenon has a rich history of leveraging its expertise in ion channel genetics to pioneer treatments for epilepsy and other neurological conditions. Their pipeline includes promising candidates like XEN1101, which is in advanced clinical trials for epilepsy.

Recent Posts by Xenon Pharmaceuticals

1-20 of 40